FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386899069> ?p ?o ?g. }

• W4386899069 abstract "<p class=MsoNormal style=text-align: justify;><strong><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;>Background:</span></strong><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;> The objective of this study was to compare the cost of outpatient ferric carboxymaltose (FCM; Ferinject&reg;) versus Iron sucrose complex (ISC; Ferosac&reg;), two prevalent intravenous iron therapy used in the treatment of iron-deficiency anemia (IDA) in the Kingdom of Saudi Arabia (KSA) from a tertiary care hospital perspective.</span></p> <p class=MsoNormal style=text-align: justify;><strong><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;>Methods:</span></strong><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;> A retrospective study was performed for all patients who were administered FCM in the outpatient clinical setting at Prince Sultan Military Medical City from January 1, 2019, until December 31, 2019. The descriptive data was analyzed using Microsoft Excel 2019 (Microsoft Corporation, Redmond, WA, USA). The total cost of treatment reflected the cost of drugs, the cost of disposables for each infusion, drug monitoring costs during infusion, the cost of productivity loss, and patient traveling cost.</span></p> <p class=MsoNormal style=text-align: justify;><strong><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;>Result:</span></strong><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;> Overall, 993 patients with IDA, treated with FCM in 1,688 outpatient visits were recruited in the study. In the outpatient setting, the per annum cost of treatment was SAR 1,434,092.50 with FCM treatment and</span><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi;> </span><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;>SAR 1,715,299.70 with ISC treatment, with a corresponding saving of 16.4% (SAR 281,207.20) with FCM. The cost savings with FCM treatment can be attributed to the reduced frequency of patient visits and corresponding reduction in drug monitoring costs (SAR </span><span lang=EN-GB style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-fareast-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB;>266,995.20;</span><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;>77.3%), loss of productivity per year (SAR </span><span lang=EN-GB style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-fareast-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB;>163,550.20; </span><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;>77.3%), and cost of transportation per year (SAR </span><span lang=EN-GB style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-fareast-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB;>573,920.00; </span><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;>77.3%).</span></p> <p class=MsoNormal style=text-align: justify;><strong><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;>Conclusion:</span></strong><span style=font-size: 12.0pt; line-height: 200%; font-family: 'Times New Roman',serif; mso-ascii-theme-font: major-bidi; mso-hansi-theme-font: major-bidi; mso-bidi-theme-font: major-bidi; mso-bidi-language: EN-US;> The use of FCM, as opposed to ISC resulted in a reduced number of iron infusions (4.4 visits for ISC as compared to one visit for FCM), accompanied by a reduction in the total cost. FCM may represent a cost-saving option compared with the existing alternative therapy used for the management of IDA in KSA.</span></p>" @default.
• W4386899069 created "2023-09-21" @default.
• W4386899069 creator A5007571767 @default.
• W4386899069 creator A5017687163 @default.
• W4386899069 creator A5020698283 @default.
• W4386899069 creator A5028694062 @default.
• W4386899069 creator A5084402007 @default.
• W4386899069 creator A5092910544 @default.
• W4386899069 date "2023-08-20" @default.
• W4386899069 modified "2023-10-09" @default.
• W4386899069 title "A cost-comparative analysis of intravenous Ferric Carboxymaltose versus Iron Sucrose for the ambulatory treatment of Iron-deficiency Anemia in a major tertiary care hospital in Saudi Arabia" @default.
• W4386899069 cites W1956820966 @default.
• W4386899069 cites W1974303718 @default.
• W4386899069 cites W1997983282 @default.
• W4386899069 cites W1998479635 @default.
• W4386899069 cites W2018273390 @default.
• W4386899069 cites W2020862550 @default.
• W4386899069 cites W2022980283 @default.
• W4386899069 cites W2026270807 @default.
• W4386899069 cites W2035675177 @default.
• W4386899069 cites W2070846234 @default.
• W4386899069 cites W2096053912 @default.
• W4386899069 cites W2102485252 @default.
• W4386899069 cites W2104912233 @default.
• W4386899069 cites W2105158897 @default.
• W4386899069 cites W2143025931 @default.
• W4386899069 cites W2160432438 @default.
• W4386899069 cites W2171975185 @default.
• W4386899069 cites W2179358297 @default.
• W4386899069 cites W2286194308 @default.
• W4386899069 cites W2330912863 @default.
• W4386899069 cites W2548086187 @default.
• W4386899069 cites W2559952413 @default.
• W4386899069 cites W2765394563 @default.
• W4386899069 cites W2941747284 @default.
• W4386899069 cites W2995875541 @default.
• W4386899069 cites W2999247438 @default.
• W4386899069 cites W3006070987 @default.
• W4386899069 cites W3043144427 @default.
• W4386899069 cites W3049350335 @default.
• W4386899069 cites W3109581377 @default.
• W4386899069 cites W3117580496 @default.
• W4386899069 cites W3138299848 @default.
• W4386899069 cites W4211008331 @default.
• W4386899069 doi "https://doi.org/10.61466/ijcmr1010005" @default.
• W4386899069 hasPublicationYear "2023" @default.
• W4386899069 type Work @default.
• W4386899069 citedByCount "0" @default.
• W4386899069 crossrefType "journal-article" @default.
• W4386899069 hasAuthorship W4386899069A5007571767 @default.
• W4386899069 hasAuthorship W4386899069A5017687163 @default.
• W4386899069 hasAuthorship W4386899069A5020698283 @default.
• W4386899069 hasAuthorship W4386899069A5028694062 @default.
• W4386899069 hasAuthorship W4386899069A5084402007 @default.
• W4386899069 hasAuthorship W4386899069A5092910544 @default.
• W4386899069 hasBestOaLocation W43868990691 @default.
• W4386899069 hasConcept C111919701 @default.
• W4386899069 hasConcept C126322002 @default.
• W4386899069 hasConcept C142362112 @default.
• W4386899069 hasConcept C153349607 @default.
• W4386899069 hasConcept C187212893 @default.
• W4386899069 hasConcept C2776732101 @default.
• W4386899069 hasConcept C2776974161 @default.
• W4386899069 hasConcept C2777417653 @default.
• W4386899069 hasConcept C2777737414 @default.
• W4386899069 hasConcept C2778248108 @default.
• W4386899069 hasConcept C3020614022 @default.
• W4386899069 hasConcept C33566652 @default.
• W4386899069 hasConcept C41008148 @default.
• W4386899069 hasConcept C71924100 @default.
• W4386899069 hasConceptScore W4386899069C111919701 @default.
• W4386899069 hasConceptScore W4386899069C126322002 @default.
• W4386899069 hasConceptScore W4386899069C142362112 @default.
• W4386899069 hasConceptScore W4386899069C153349607 @default.
• W4386899069 hasConceptScore W4386899069C187212893 @default.
• W4386899069 hasConceptScore W4386899069C2776732101 @default.
• W4386899069 hasConceptScore W4386899069C2776974161 @default.
• W4386899069 hasConceptScore W4386899069C2777417653 @default.
• W4386899069 hasConceptScore W4386899069C2777737414 @default.
• W4386899069 hasConceptScore W4386899069C2778248108 @default.
• W4386899069 hasConceptScore W4386899069C3020614022 @default.
• W4386899069 hasConceptScore W4386899069C33566652 @default.
• W4386899069 hasConceptScore W4386899069C41008148 @default.
• W4386899069 hasConceptScore W4386899069C71924100 @default.
• W4386899069 hasIssue "1" @default.
• W4386899069 hasLocation W43868990691 @default.
• W4386899069 hasOpenAccess W4386899069 @default.
• W4386899069 hasPrimaryLocation W43868990691 @default.
• W4386899069 hasRelatedWork W1492831809 @default.
• W4386899069 hasRelatedWork W2070305242 @default.
• W4386899069 hasRelatedWork W2089588575 @default.
• W4386899069 hasRelatedWork W2130192910 @default.
• W4386899069 hasRelatedWork W2325465817 @default.
• W4386899069 hasRelatedWork W2356041998 @default.
• W4386899069 hasRelatedWork W2891853812 @default.
• W4386899069 hasRelatedWork W3032485423 @default.
• W4386899069 hasRelatedWork W3169973109 @default.
• W4386899069 hasRelatedWork W1570122258 @default.
• W4386899069 hasVolume "1" @default.
• W4386899069 isParatext "false" @default.

• next